The medical mask market size to cross USD 9.5 billion by 2020, growing at a CAGR of 26% during the forecast period. The global medical mask market size is expected to reach a staggering volume of over 52 billion units by the end of 2020 due to the eruption of the COVID-19 pandemic. The market is expected to stabilize in 2021, reaching 29 billion units by 2025. The growth is mainly due to the rising prevalence of several acute and chronic respiratory diseases across the globe. It is expected that patients, as well as healthcare professionals, continue to demand advanced medical face to treat and prevent acute & chronic diseases. The emergence of pandemics, such as COVID-19, will drive the growth of the market. Moreover, the introduction of 3-D printed medical masks with accuracy and improved safety and efficacy in recent years is also likely to drive future market growth across the globe.
- The respirator product segment is likely to witness the highest growth rate over the forecast period.
- The hospitals end-user segment is expected to observe an incremental growth of over 12 billion units by 2025 due to the larger uptake of medical masks in several private and public hospitals across the globe.
- Innovations such as transparent, 3-D printed medical face masks, and the expansion of manufacturing and production capacities are also expected to fuel the market growth during the forecast period.
- In terms of unit shipments, Europe is expected to lead the global medical mask market on account of the eruption of COVID-19 pandemic. The European Commission is working with industry and Member States to maximize the availability of surgical and respirator masks.
MEDICAL MASK MARKET SEGMENTATION
This research report includes a detailed segmentation by
INSIGHTS BY PRODUCTS
The surgical medical mask segment is likely to grow at a healthy rate with a growing number of surgical procedures across the globe. Surgical masks can prevent infections in patients and HCPs by catching bacteria shed in liquid droplets and aerosols from the wearer's mouth and nose. They are considered as the primary protection standard by medical professionals in almost low, medium, or high level medical and laboratory experimental procedures. The growing recommendation of specific surgical masks by healthcare professionals in the community and home settings for patients to avoid close contact and to maintain good hand hygiene is another factor driving the demand for the segment.
The surge in the COVID-19 pandemic across the world has increased the demand for respirator masks, particularly among HCPs that are working in health care facilities. There has been a surge due to the COVID-19 pandemic, with around 6.6 million reported infected cases globally as of June 4, 2020. Therefore, respirator masks offer more protection than surgical ones because they can filter out both large as well as small particles. Thus, the CDC recommends the use of respirator masks as protective equipment for frontline healthcare workers and strategizes for optimizing the supply of these for seamless manufacturing and supply of the products to combat the pandemic.
INSIGHTS BY END-USERS
In terms of revenue, the hospital end-user segment is expected to grow at the highest CAGR during the forecast period. High adoption of latest generation treatment practices with standard hygiene and safety measures is driving the market. A majority of patients with a high risk of diseases prefer visiting hospitals for treatment due to advanced infrastructure care facilities available in major private and public hospitals. Surgeons prefer to use modern medical masks made of non-allergic materials due to their high success rates and improved patient outcomes during complex medical surgeries. The medical mask market in India is the third-largest in the Asia Pacific region. Amid the coronavirus outbreak, the government of India has ramped up domestic manufacturing of PPE, including medical face masks, for healthcare workers to meet the excessive demand.
The clinic segment is expected to grow mainly on account of the growing prevalence of several acute and chronic diseases and associated surgeries, infections, and injuries. HCPs in the clinics use medical masks for adequate barrier protection for themselves and patients while treating patients with diseases. In developing countries such as China, India, Russia, and Africa, where the majority of the rural population lives, the healthcare sector is provided by mobile health clinics or roadside dispensaries that also need the significant use of medical face masks to prevent contaminations and infections.
The diagnostic laboratories' end-user segment is growing at a steady rate primarily due to the widespread use of examination medical face masks in laboratory settings. The segment includes both public health laboratories and reference laboratories. Typically, public health laboratories are run by state and local health departments to diagnose and protect the population from health threats such as outbreaks of infectious diseases such as COVID-19.
INSIGHTS BY GEOGRAPHY
With around 6.6 million confirmed COVID-19 infected cases as on June 4, 2020, North America is likely to dominate the medical mask market share with the unit share expected to reach over 7.8 billion units by 2025. In the US alone, there is a high demand for medical face masks among healthcare professionals to protect themselves from the virus infection. According to CDC recommendations, surgical masks and N-95 respirators are critical for healthcare workers. The market in this region is characterized by high penetration of advanced masks such as transparent and 3-D printed ones. Also, with the favorable government financial support for many surgical procedures, resulting in high uptake of surgical masks, respirators, North America offers tremendous growth opportunities, thereby the market is expected to continue to grow during the upcoming periods.
APAC accounted for the third-largest market share in the global medical mask market and contributed a volume share of 23% in 2019. The market in APAC is growing at a significant rate and is expected to grow at a similar pace during the forecast period. The major revenue contributors in APAC are China, Japan, India, South Korea, and Australia.
INSIGHTS BY VENDORS
The global medical mask market share is fragmented and is highly competitive and dynamic. The presence of several global, regional, and local vendors offers a diverse range of surgical and respirator medical face masks to end-users. Approximately 400 vendors are offering a wide array of medical face masks worldwide. With the outbreak of COVID-19, the number of companies manufacturing these has increased exponentially, especially in China. China has become the largest manufacturing hub, and around 50% of the global production is from China alone. Strategic partnerships, capacity expansion, and differentiated products have fuelled the growth in recent years. New product launches, capacity expansion, collaborations are expected to be crucial for companies to maintain revenue growth in the coming years.
The medical mask market research report includes in-depth coverage of the industry analysis with revenue and forecast insights for the following segments:
Segmentation by Products
- Diagnostic Laboratories
- North America
- The Netherlands
- South Korea
- Latin America
- Middle East & Africa
- Saudi Arabia
- South Africa